Literature DB >> 12489105

Neuropsychiatric applications of DTI - a review.

K O Lim1, J A Helpern.   

Abstract

Psychiatric disorders are common throughout the world and are a leading cause of disability. There is a growing appreciation of the importance of connectivity to brain function. Disruption of this connectivity can result in brain dysfunction manifested in impaired cognitive functioning and the development of clinical symptoms. White matter forms the basis of anatomical connectivity. Diffusion tensor imaging (DTI) is a useful tool for examining and quantifying white matter microstructure. Clinical research studies in alcoholism, HIV-1 infection, geriatric depression and schizophrenia using DTI have revealed abnormalities in white matter microstructure. The use of complementary imaging methods may be helpful in further characterizing these abnormalities. Other psychiatric disorders may also have white matter involvement amenable to study with DTI. Advances in acquisition and analysis methods will be necessary to further advance work in this field. The study of animal models and postmortem tissue may be helpful in elucidating the neurobiological underpinnings of abnormalities observed with DTI. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12489105     DOI: 10.1002/nbm.789

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  73 in total

1.  Evidence for white matter abnormalities in schizophrenia.

Authors:  Marek Kubicki; Robert W McCarley; Martha E Shenton
Journal:  Curr Opin Psychiatry       Date:  2005-03       Impact factor: 4.741

Review 2.  Translating glutamate: from pathophysiology to treatment.

Authors:  Daniel C Javitt; Darryle Schoepp; Peter W Kalivas; Nora D Volkow; Carlos Zarate; Kalpana Merchant; Mark F Bear; Daniel Umbricht; Mihaly Hajos; William Z Potter; Chi-Ming Lee
Journal:  Sci Transl Med       Date:  2011-09-28       Impact factor: 17.956

3.  Intrinsic Regression Models for Positive-Definite Matrices With Applications to Diffusion Tensor Imaging.

Authors:  Hongtu Zhu; Yasheng Chen; Joseph G Ibrahim; Yimei Li; Colin Hall; Weili Lin
Journal:  J Am Stat Assoc       Date:  2009       Impact factor: 5.033

4.  Diffusion tensor imaging in hydrocephalus: initial experience.

Authors:  Y Assaf; L Ben-Sira; S Constantini; L C Chang; L Beni-Adani
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

5.  Diffusion-tensor MR imaging of the brain in human immunodeficiency virus-positive patients.

Authors:  Majda M Thurnher; Mauricio Castillo; Alfred Stadler; Armin Rieger; Brigitte Schmid; Pia C Sundgren
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

Review 6.  Neurocircuitry in alcoholism: a substrate of disruption and repair.

Authors:  Edith V Sullivan; Adolf Pfefferbaum
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

Review 7.  Advances in white matter imaging: a review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging.

Authors:  Jeffrey R Wozniak; Kelvin O Lim
Journal:  Neurosci Biobehav Rev       Date:  2006-08-07       Impact factor: 8.989

8.  A method for clustering white matter fiber tracts.

Authors:  L J O'Donnell; M Kubicki; M E Shenton; M H Dreusicke; W E L Grimson; C F Westin
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

9.  Using perturbation theory to compute the morphological similarity of diffusion tensors.

Authors:  R Bansal; L H Staib; D Xu; A F Laine; J Royal; B S Peterson
Journal:  IEEE Trans Med Imaging       Date:  2008-05       Impact factor: 10.048

10.  Cognitive control and white matter callosal microstructure in methamphetamine-dependent subjects: a diffusion tensor imaging study.

Authors:  Ruth Salo; Thomas E Nordahl; Michael H Buonocore; Yutaka Natsuaki; Christy Waters; Charles D Moore; Gantt P Galloway; Martin H Leamon
Journal:  Biol Psychiatry       Date:  2008-09-23       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.